KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Treasury Shares (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Treasury Shares for 10 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 31.21% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 31.21% year-over-year, with the annual reading at $1.7 million for FY2025, 31.21% up from the prior year.
  • Treasury Shares for Q4 2025 was $1.7 million at Biolife Solutions, up from $1.4 million in the prior quarter.
  • The five-year high for Treasury Shares was $1.9 million in Q3 2022, with the low at $139756.0 in Q4 2021.
  • Average Treasury Shares over 5 years is $1.0 million, with a median of $1.1 million recorded in 2021.
  • The sharpest move saw Treasury Shares crashed 79.86% in 2021, then skyrocketed 1244.64% in 2022.
  • Over 5 years, Treasury Shares stood at $139756.0 in 2021, then surged by 1244.64% to $1.9 million in 2022, then plummeted by 72.91% to $509166.0 in 2023, then skyrocketed by 154.46% to $1.3 million in 2024, then surged by 31.21% to $1.7 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.7 million, $1.4 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.